379 related articles for article (PubMed ID: 16006130)
1. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
Ozensoy O; Nishimori I; Vullo D; Puccetti L; Scozzafava A; Supuran CT
Bioorg Med Chem; 2005 Nov; 13(22):6089-93. PubMed ID: 16006130
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozymes IX and XII with a library of aromatic and heteroaromatic sulfonamides.
Ozensoy O; Puccetti L; Fasolis G; Arslan O; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Nov; 15(21):4862-6. PubMed ID: 16168653
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
Nishimori I; Vullo D; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT
Bioorg Med Chem Lett; 2005 Sep; 15(17):3828-33. PubMed ID: 16039848
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem Lett; 2009 Jun; 19(12):3170-3. PubMed ID: 19435663
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
Vullo D; Innocenti A; Nishimori I; Pastorek J; Scozzafava A; Pastoreková S; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):963-9. PubMed ID: 15686894
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.
Winum JY; Thiry A; Cheikh KE; Dogné JM; Montero JL; Vullo D; Scozzafava A; Masereel B; Supuran CT
Bioorg Med Chem Lett; 2007 May; 17(10):2685-91. PubMed ID: 17376683
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.
Zimmerman S; Innocenti A; Casini A; Ferry JG; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Dec; 14(24):6001-6. PubMed ID: 15546717
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
Mincione F; Starnotti M; Masini E; Bacciottini L; Scrivanti C; Casini A; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Sep; 15(17):3821-7. PubMed ID: 16039853
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX.
Turkmen H; Durgun M; Yilmaztekin S; Emul M; Innocenti A; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jan; 15(2):367-72. PubMed ID: 15603956
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides.
Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
Bioorg Med Chem Lett; 2007 Feb; 17(4):987-92. PubMed ID: 17157501
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
Innocenti A; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(22):5703-7. PubMed ID: 15482952
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII.
Rami M; Winum JY; Innocenti A; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2008 Jan; 18(2):836-41. PubMed ID: 18042384
[TBL] [Abstract][Full Text] [Related]
16. QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamides.
Tarko L; Supuran CT
Bioorg Med Chem; 2007 Sep; 15(17):5666-71. PubMed ID: 17574422
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
Nishimori I; Vullo D; Minakuchi T; Morimoto K; Onishi S; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Apr; 16(8):2182-8. PubMed ID: 16459077
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
Nishimori I; Minakuchi T; Onishi S; Vullo D; Scozzafava A; Supuran CT
J Med Chem; 2007 Jan; 50(2):381-8. PubMed ID: 17228881
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered.
Vullo D; Scozzafava A; Pastorekova S; Pastorek J; Supuran CT
Bioorg Med Chem Lett; 2004 May; 14(9):2351-6. PubMed ID: 15081039
[TBL] [Abstract][Full Text] [Related]
20. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Szafrański K; Vullo D; Supuran CT
Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
